Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: Spectral analysis of fibrillation waves in the Holter monitoring

Europace

Volumn 9, Issue 12, 2007, Pages 1209-1215

  Niwano, Shinichi ^a   Fukaya, Hidehira ^a   Sasaki, Takeshi ^a   Hatakeyama, Yuko ^a   Fujiki, Akira ^b   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atrial fibrillation; Calcium channel blocker; Electrical remodelling; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; VERAPAMIL;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; SPECTROSCOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; ELECTROCARDIOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADULT; AGED; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SPECTRUM ANALYSIS; VERAPAMIL;

EID: 39849105941     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum199     Document Type: Article

References (26)

1. Wiffels MC, Kirchohof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation; a study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
2. Tieleman RG, Van Gelder IC, Crijns HJGM, De Kam PJ, Van Den Berg MP, Haaksma J et al. Early recurrence of atrial fibrillation after electrical cardioversion; a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-73.
3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-74.
4. Daoud EG, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-50.
5. Moriguchi M, Niwano S, Yoshizawa N, Kojima J, Inuo K, Sasaoka T et al. Verapamil suppresses the inhomogeneity of electrical remodeling in a canine chronic rapid atrial stimulation model. Pacing Clin Electrophysiol 2003;26:2072-82.
6. Bertaglia E, D'Este D, Zerbo F, Michieletto M, Pascotto P. Effects of verapamil and metoprolol on recovery from atrial electrical remodeling after cardioversion of long-lasting atrial fibrillation. Int J Cardiol 2003;87:167-72.
7. Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y et al. A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 2004;44:386-92.
8. Kinebuchi O, Mitamura H, Shiroshita-Takeshita A, Kurita Y, Ieda M, Ohashi N et al. Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium. Circ J 2004;68:494-500.
9. Meurling CJ, Ingemansson MP, Roijer A, Carlson J, Lindholm CJ, Smideberg B et al. Attenuation of electrical remodeling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999;1:234-41.
10. Bollmann A, Sonne K, Esperer HD, Toepffer I, Klein HU. Patients with persistent atrial fibrillation taking oral verapamil exhibit a lower atrial frequency on the ECG. Ann Noninvasive Electrocardiol 2002;7:92-7.
11. Niwano S, Yumoto Y, Yoshizawa N, Hara H, Saito J, Moriguchi M et al. Oral verapamil suppresses the recurrence of paroxysmal atrial fibrillation in human. Suppression of the atrial electrical remodeling as the possible mechanism. Europace 2000;1: 167-70.
12. Tieleman RG, Blaauw Y, Van Gelder IC, De Langen CD, de Kam PJ, Grandjean JG et al. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation 1999;100:1836-42.
13. Niwano S, Wakisaka Y, Kojima J, Yumoto Y, Inuo K, Hara H et al. Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. Analysis of the f-f interval during atrial fibrillation in the ambulatory ECG monitoring. Circ J 2003;67:133-8.
14. Sasaki T, Niwano S, Sasaki S, Imaki R, Yuge M, Hirasawa S et al. Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation-spectral analysis of surface ECG. Circ J 2006;70:169-73.
15. Fujiki A, Nagasawa H, Sakabe M, Sakurai K, Nishida K, Mizumaki K et al. Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J 2000;65:1047-51.
16. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
17. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-35.
18. Blaauw Y, Tieleman RG, Brouwer J, Den Berg Van, De Kam PJ, De Langen CD et al. Tachycardia induced electrical remodeling of the atria and the autonomic nervous system in goats. Pacing Clin Electrophysiol 1999;22:1656-67.
19. Moriguchi M, Niwano S, Yoshizawa N, Kitano Y, Kojima J, Inuo K et al. Inhomegeneity in appearance of the electrical remodeling during chronic rapid atrial pacing: evaluation of the dispersion of the atrial effective refractoriness. Jpn Circ J 2001;65:335-40.
20. Bollmann A, Sonne K, Esperer HD, Toepffer I, Langberg JJ, Klein HU. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovasc Res 1999;44:60-6.
21. Duytschaever M, Mast F, Allessie M. Pro-fibrillatory effects of verapamil in a goat model of atrial fibrillation. (Abstract). Pacing Clin Electrophysiol 1998;21:199.
22. Ingemansson MP, Holm M, Olsson SB. Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation. Heart 1998;80:71-6.
23. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats. Circulation 1997;96:3710-20.
24. Bayer R, Kalusche D, Kaufmann R, Mannhold R. Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. Naunyn Schmiedebergs Arch Pharmacol 1975;290:81-97.
25. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators: a comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
26. Tsuneda T, Yamashita T, Fukunami M, Kumagai K, Niwano S, Okumura K et al. Rate control and quality of life in patients with permanent atrial fibrillation. The quality of life and atrial fibrillation (QOLAF) study. Circ J 2006;70:965-70.